In this protocol, Dr. Hankins reviews the pathophysiology, diagnosis, and management of external cephalic version. Included are step-by-step guidelines for performing the procedure with illustrations of the manuevers required for successful cephalic version with 2 operators or 1.
AUTHOR: GARY D. V. HANKINS, PROFESSOR AND CHAIR, DEPARTMENT OF OBSTETRICS AND GYNECOLOGY, AND JENNIE SEALY DISTINGUISHED PROFESSOR IN OBSTETRICS AND GYNECOLOGY, UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON
SYNOPSIS: Dr. Hankins reviews the pathophysiology, diagnosis, and management of external cephalic version. Included are step-by-step guidelines for performing the procedure with illustrations of the maneuvers required for successful cephalic version with 2 operators or 1.
As the author notes, careful assessment of fetal presentation in the third trimester is important. Otherwise, patients may be deprived of the option of external cephalic version to decrease the risk of cesarean delivery. Before the procedure, fetal well-being and the presence of any contraindications should be ascertained. Informed consent and counseling with regard to the likelihood of success of the procedure should be performed. Post-version assessment for fetal presentation on subsequent encounters is vital in these patients.
BUY the book ( http://www.wiley.com/WileyCDA/WileyTitle/productCd-1405196505.html)
WATCH an interview with Drs. Queenan and Spong here: http://www.youtube.com/watch?v=pdgqNUOtnk4
Hormone therapy safety: Study finds potential benefits for senior women
April 24th 2024A recent large-scale study challenged age-related concerns, suggesting hormone therapy may offer safety and even benefits for menopausal women aged over 65 years, aligning with The Menopause Society's 2022 Position Statement.
Read More
Hyperoxygenation use not linked to neonatal outcomes
April 23rd 2024Recent research evaluated the impact of maternal hyperoxygenation on neonatal Apgar scores, revealing no significant enhancement in outcomes among women with pathologic fetal heart rate tracing and suggesting limited efficacy of hyperoxygenation therapy in this context.
Read More
Study finds antihypertensive treatment reduces uterine fibroids risk
April 23rd 2024A recent study revealed that patients with untreated or new-onset hypertension face elevated chances of uterine fibroid diagnosis, underscoring the potential of antihypertensive therapy in mitigating this risk among midlife individuals.
Read More